SYNOPSIS Alterations of the coagulation potential of heparinized blood after using an extracorporeal circulation have been studied by means of a toluidine blue-calcium chloride reagent. This technique was originally used to detect the effect of activation by contact on the coagulation mechanism in heparinized blood. It has been shown that it also detects, in the presence of heparin, the clotpotentiating effect of blood cell contents liberated in vitro by mechanical trauma to blood.
Activation of coagulation and fibrinogen loss after using an extracorporeal circulation after perfusion is more difficult. It is reasonable to assume such activation when fibrin deposits are present in the circuit. The tendency for these to form on glass surfaces or at points in the circuit where blood is subjected to trauma was noted by several earlier workers (Stokes and Gibbon, 1950; Dennis, Karlson, Eder, Nelson, Eddy, and Sanderson, 1951; Clowes, Neville, Hopkins, Anzola, and Simeone, 1954) . With improved apparatus and technique such deposits are now uncommon and histological evidence of fibrin emboli is seldom obtained. Nevertheless coagulation defects still occur and have been reported even in the absence of detectable fibrinogen loss (Fantl and Ward, 1960) .
The demonstration of activation of coagulation in these circumstances depends upon laboratory tests. The presence of heparin in samples to be tested makes orthodox methods impracticable and most of the support for activation of coagulation after perfusion is derived from indirect evidence.
The object ofthispaper is todescribetheapplication of a toluidine blue-calcium chloride reagent (Bloom, 1962) to the study of coagulation activity in heparinized blood. Evidence will be presented to show the development of increased coagulation potential in heparinized blood recirculated in a heart-lung machine in vitro and after experimental and clinical perfusion for open-heart surgery, and an attempt will be made to relate the changes to the development of fibrinogen loss. The evidence supports the hypothesis that activation of the coagulation mechanism during perfusion plays a part in the development of coagulation defects.
MATERIALS AND STANDARD METHODS
COLLECTION OF SPECIMENS Blood was collected using siliconed syringes and containers. For coagulation studies it was taken into 3-8 % w/v trisodium citrate in the ratio of nine volumes of blood to one of citrate. Platelet-poor plasma was obtained by centrifuging at 3,000 r.p.m. for 30 minutes. Blood for cell counts and plasma haemoglobin estimations was taken into the dipotassium salt of ethylene diamine tetra-acetic acid (E.D.T.A.). For plasma fibrinogen estimation blood was taken into dried potassium oxalate (2 5 mg./ml.) and plasma obtained by centrifuging at 3,000 r.p.m. for 10 minutes. HEPARIN SOLUTION, INTACT PLASMA, CEPHALIN, AND GLASS-WARE These were prepared as described by Bloom (1962) .
PLASMA HAEMOGLOBIN This was estimated by the method of Fielding and Langley (1958) .
CELL COUNTS White cell counts were performed as described by Whitby and Britton (1953) . Platelet counts were performed by the method of Baar (1948) .
PLASMA FIBRINOGEN This was estimated by the method described by Varley (1960) modified as follows: Plasma, 0 1 ml., was added to 0 25 ml. of normal saline, and to the mixture was added 01 ml. of a solution of polybrene, 10 mg. % in normal saline, and 0 1 ml. of a 1 % solution of epsilon amino-caproic acid (E.A.C.A.). The plasma was clotted at 37°C. with calcium chloride and subsequently the fibrin was estimated as tyrosine as described by Varley. Polybrene was added to neutralize heparin, and E.A.C.A. to minimize possible fibrinolysis during the performance of the test. Epsilon amino-caproic acid is an inhibitor of fibrinolytic activation (Ablondi, Hagan, Philips, and De Renzo, 1959) . Preliminary studies were performed to ensure that the addition of these substances to plasma did not affect the fibrinogen estimation.
Fibrinogen estimations were performed on 0-1 ml. volumes of eight different normal plasma samples adding 0 1 ml. of heparin, 4units/ml.,and 0.1 ml. ofpolybrene and E.A.C.A. as described above. Simultaneous estimations were performed on aliquots of the same plasma substituting equal volumes of saline for the heparin, polybrene, and epsilon amino-caproic acid. The results are shown in Table I . The addition of heparin, polybrene, and E.A.C.A. to plasma does not affect the fibrinogen estimation. The importance of contact with glass and other forms of silica and adsorbants in the activation of the coagulation mechanism has been demonstrated by the work of Margolis (1957) , Ratnoff and Rosenblum (1958), and Soulier and Prou-Wattelle (1960) , and substances active in this respect, such as stainless steel (Rose and Broida, 1954) , are used in extracorporeal circuits. In a previous paper Bloom (1962) described the use of the toluidine blue-calcium chloride reagent to demonstrate activation ofthe coagulation mechanism in heparinized plasma when in contact with glass. During extracorporeal circulation of blood, coagulation activity may be affected not only by contact with foreign surfaces but also by products liberated from destroyed blood cells. Substances active in coagulation are present in platelets (Van Creveld and Paulssen, 1952; Deutsch, Johnson, and Seegers, 1955) , red cells (Quick, Georgatsos, and Hussey, 1954; Desmet, Verstraete, and Vandenbroucke, 1957) and possibly in white cells (Gollub, 1953; O'Brien, 1959) . Preliminary to studies with an extracorporeal circulation experiments were therefore carried out to demonstrate the effects of cellular damage on coagulation activity of normal blood and to determine if these could be detected in heparinized blood by using the toluidine bluecalcium chloride reagent.
CHANGES IN NORMAL BLOOD DAMAGED MECHANICALLY
Citrated blood, 2 ml., was delivered into each of two tubes. Fifteen siliconed glass beads, 2 mm. in diameter, were placed in one tube which was stoppered with a polythene-covered rubber bung and rotated on a Matburn mixer at 28 r.p.m. for about 15 minutes. The second tube was left unrotated. The blood from both tubes was transferred to fresh ones and samples removed for cell counts. The remainder was centrifuged at 3,000 r.p.m. for 30 minutes and the cell-poor plasma was removed. This Sample Tested was then tested by the silicone calcium clotting time technique with and without cephalin. To control the absence of contact activation by siliconed beads, intact normal plasma was rotated with such beads at the same time as the blood and subsequently tested. At no time did unsiliconed glass come into contact with the blood or plasma.
The results are shown in Table II . Trauma to blood by rotation with siliconed glass beads leads to release of haemoglobin and loss of platelets. The changes in the white cell counts were insignificant. These cellular changes were accompanied by acceleration of the plasma silicone clotting times. This occurred in the absence of contact with glass and was not observed to a significant extent when intact plasma was rotated with siliconed beads. It is concluded that the accelerated clotting times are due to substances liberated from blood cells. The addition of cephalin to the test system accelerated clotting but the effects of cellular products could still be detected.
DETECTION OF CHANGES IN HEPARINIZED BLOOD DAMAGED
MECHANICALLY Heparinized blood was prepared by adding 0 1 ml. of a solution of heparin, 40 units/ml., to 4 ml. of citrated venous blood. The final concentration of heparin was thus approximately 1 unit/ml., i.e., about 2 units/ml. in plasma. This concentration is completely neutralized by the toluidine blue-calcium chloride reagent (Bloom, 1962) . Non-heparinized blood was prepared by substituting normalsaline for the heparin.Samples of each were subjected to trauma with siliconed glass beads as described above, and the cell-poor plasma was tested using both M/20 calcium chloride and the toluidine blue-calcium chloride reagent.
The results are shown in Table III . The accelerating effects of trauma to whole blood on the plasma silicone clotting times is easily detected with the toluidine blue-calcium chloride reagent, although the presence of the dye prolongs the clotting times. When plasma from heparinized blood is tested with the reagent, the results are very similar to those obtained with non-heparinized blood. The slight differences observed are probably due to variations which occur in the extent of cellular destruction even when the same number of glass beads is used. It group.bmj.com on November 6, 2017 -Published by http://jcp.bmj.com/ Downloaded from blood in some animals. Further increases in plasma haemoglobin occurred in all experiments after recirculation. These varied from 10 to 170 mg. %.
White cell and platelet counts are shown in Figure 3 . Platelet counts were surprisingly little affected although clumping made accurate counting difficult. In only three experiments (1, 5, and 8) did appreciable loss of platelets occur. White cell counts were not greatly affected but a loss of over 10 % was observed in four experiments (1, 2, 5 and 7). Acceleration of the clotting times was most marked in the two experiments (1 and 5) in which the greatest cellular destruction was detected.
ACTIVATION OF THE COAGULATION MECHANISM DURING PERFUSION The object of these studies was to investigate the changes in the coagulation potential of heparinized blood during clinical and experimental perfusion for open-heart surgery.
Donor blood for priming the heart-lung machine was collected for patients on the day before operation into E.D.T.A. as anticoagulant and was stored overnight at 4°C. Before operation each unit of 500 ml.was heparinized with 2,500 units of heparin and recalcified with 1-8 ml. of 10% calcium chloride. Donor blood for experimental perfusion of sheep was collected on the morning of operation. One pint was collected from each animal and was taken into heparin (2,500 units/500 ml.) in siliconed glass bottles. The blood for these experiments was not that used for the recirculation experiments.
Patients and animals received heparin at a dosage of 250 units per kilogram body weight.
The perfusions were all short, i.e., up to 40 minutes' duration. After perfusion heparin was neutralized by intravenous infusion during 10 minutes of polybrene in a dose ratio of 0-75 to 1 mg. for sheep and 1-25 to 1-5 mg. for patients to each 100 units of heparin administered. Neutralization was checked by the thrombin clotting time and further graded doses of polybrene given if indicated. This was actually needed in only one instance.
Samples of blood were obtained from patients and Figure 4 records the clotting times without cephalin and Fig. 5 those with cephalin.
The clotting times of the mixed donor blood tended to be shorter than those of the pre-perfusion samples of the subject. At the end of perfusion, however, clotting with and without cephalin was always accelerated, usually considerably so, and clotting times shorter than those of the mixed donor blood were always obtained. This increased clotting potential in the heparinized blood was usually short lived. Fifteen to 20 minutes after perfusion following the administration of polybrene only five samples, all from sheep, still showed accelerated clotting times. The human samples and those from the other sheep showed a greater or lesser degree of impaired coagulation.
Increased clotting potential in the heparinized blood at the end of perfusion was thus often replaced by impaired clotting by the time the circulating heparin had been neutralized.
The mean values for the platelet counts and plasma haemoglobin and fibinogen levels are shown in Table IV Some destruction of red cells occurred during perfusion but plasma haemoglobin levels above 50 mg. % were not observed. The mean platelet loss in the human cases during perfusion was 149,000/c.mm. and in the animals 288,000/c.mm. Clumping of platelets was usually present in the pooled donor blood in the animal experiments and may account for the relatively low counts observed in this blood.
The mean loss of plasma fibrinogen in the human cases was 55 mg. % and in the animals 84 mg. %. This occurred partly during perfusion and partly during the administration of polybrene, when the mean loss in the patients was 27-4 mg. % (S.D. 5 4) and in the animals 41-4 mg. % (S.D. 11 '7). These changes differ significantly from zero (P<OO1 for patients and sheep).
The changes occurring in the toluidine bluecalcium chloride clotting times and in the platelet counts, plasma haemoglobin and fibrinogen levels are summarized graphically in Figure 6 . The changes occurring during human perfusions were similar to those observed in the animal experiments and the mean values for the combined series are shown in the figure.
Increased coagulation potential occurring in the heparinized blood during perfusion is associated with the destruction of red cells and platelets and with mild fibrinogen loss. Further fibrinogen loss occurring during neutralization of heparin is associated with prolongation of the clotting times. These findings suggest intravascular coagulation with consumption of coagulation factors. It was not possible, however, in this small series to correlate the extent of the coagulation changes in individual subjects with that of the changes in blood cells and plasma fibrinogen levels.
DISCUSSION
Support for the hypothesis that activation of the coagulation mechanism occurs during perfusion in the absence of fibrin deposits in the circuit is based, because of the difficulty in testing heparinized blood, mainly on indirect evidence. Osborn et al. (1956) perfused dogs without using heparin and detected shortened clotting times followed by incoagulability of the blood with fibrinogen depletion. The authors attributed the changes to activation of coagulation and exhaustion of coagulation factors. Wright et al. (1958) and Hoeksema et al. (1959) drew attention to the similarity of the changes occurring in coagulation factors during extracorporeal circulation to those occurring during coagulation of blood in vitro. Gans et al. (1962) demonstrated accelerated clotting and thrombin generation in citrated blood recirculated in a heart-lung machine, and Penick, Averette, Peters, and Brinkhous (1958) have shown that transfusion of such blood in dogs leads to thrombocytopenia and loss of factor VIII. They attributed these changes to activation of the coagulation mechanism although fibrinogen levels were unaltered.
The demonstration of such changes in heparinized blood is more difficult. Perkins, Osborn, and Gerbode (1959) claimed that clotting times were accelerated and prothrombin consumption increased in samples taken immediately after perfusion and tested after careful neutralization of heparin with protamine. Later samples showed impaired coagulation. These results would support the hypothesis that coagulation is activated during perfusion but details of their experiments were not given.
In the present study a toluidine blue-calcium chloride technique has been used to detect changes in the coagulation potential of heparinized blood. This technique not only detects contact activation of coagulation in such blood (Bloom, 1962) but also the clot-accelerating effect of blood cell contents. This was more obvious when cephalin was omitted from the test system, a finding in keeping with observations that substances present in platelets, red cells, and brain cephalin have similar activity in thromboplastin generation (Bell and Alton, 1954; Quick et al., 1954; Troup and Reed, 1958) . Some acceleration of the plasma clotting times of damaged blood occurred, however, when tested even in the presence of cephalin. This suggests that blood cells also contain a different type of activity.
Increased coagulation potential developed in heparinized sheep blood during recirculation in the heart-lung machine in vitro and was associated to a greater or lesser extent with destruction of blood cells. In contrast to the findings of Nilsson and Swedberg (1959) and of Gans et al. (1962) , working with dogs' blood, but in agreement with those of Perkins, Osborn, and Gerbode (1957) (Bloom, 1962) and may contribute to the accelerated clotting times. Didisheim, Hattori, and Lewis (1959) failed to detect an effect of contact with glass on the clotting time of sheep blood. It is wrong to assume, however, that the contact phase is absent in the blood of these animals. The addition of kaolin to intact sheep plasma results in considerable shortening of the silicone calcium clotting time (personal unpublished observation). The fact that the blood was pooled in the oxygenator before sampling and thus exposed to stainless steel may account for the observation that the collection of sheep blood in siliconed or non-siliconed bottles did not appreciably affect the results. In any case the technique used will not distinguish between the effects of contact and those of cellular, products, as the addition of brain cephalin to the test system does not entirely exclude the activity of cellular elements. Whatever the mode of enhancement of the coagulation potential, complete coagulation during recirculation was prevented by heparin, and fibrinogen levels remained unaltered. This confirms the observation made by Nilsson and Swedberg (1959) and Gans et al. (1962) that the extracorporeal circuit does not denature this protein, at least during the time limits of the experiments. Fibrinogen loss during and after perfusion thus appears to be a phenomenon in vivo.
Enhanced coagulation potential was also observed in heparinized blood after clinical and experimental perfusion for open-heart surgery. Although the donor blood may have contributed to this effect it was not the only factor responsible. The clotting times of the post-perfusion samples were usually shorter than those of the mixed donor blood.
Although the enhanced coagulation potential was associated with cellular destruction, no relationship could be demonstrated in this small series between the extent of the coagulation changes in individual subjects and that of the platelet counts and plasma haemoglobin levels. This does not necessarily mean that cellular products do not contribute to the coagulation changes. These are no doubt the result of a complicated interplay of factors, including possibly the effects of the donor blood and contact activation of coagulation as well as those of cellular contents.
Recently similar enhancement of coagulation has been described by Ollendorff, Storm, Rygg, and Arnfred (1961) after extracorporeal circulation of human blood both with and without a patient. They were able to detect this by demonstrating an accelerating effect of the test plasma on thromboplastin generation in intact platelet-rich normal plasma. Heparin was neutralized with protamine and toluidine blue (Ollendorff, 1962) . The authors considered that activation of factors XII and XI by contact was responsible for the changes detected, but their technique, like that used in the present study, did not exclude the effects of cellular contents, especially as intact platelets were used in their test system. Margolis (1957) has shown that disintegration of platelets increases their activity in coagulation.
The enhanced coagulation potential after perfusion in the present study was usually shortlived and it had been replaced by impaired coagulation in most of the post-polybrene samples. This may merely represent an anticoagulant action of excess polybrene such as that described by Egerton and Robinson (1961) but other explanations are possible.
The work of Spaet and his colleagues (Spaet and Kropatkin, 1958; Spaet and Cintron, 1960; Spaet, Horowitz, and Zucker-Franklin, 1960) suggests the existence of a clearing mechanism for plasma thromboplastin and its intermediates which may be associated with the reticulo-endothelial system. Similar clearance of coagulant material may account for the rapid disappearance of activity noted in the present study.
The impaired coagulation may, however, be the result, at least in part, of consumption of coagulation factors following neutralization of heparin while the coagulation mechanism is hyperactive. Appreciable fibrinogen loss occurred during the neutralization of heparin with polybrene and at the same time impaired coagulation was detected in the postpolybrene samples. The available evidence is against precipitation by polybrene as a cause of fibrinogen loss. Unlike protamine, polybrene does not apparently precipitate fibrinogen in plasma (Godal, 1960; Shanberge, Regan, Talarico, and Busiek, 1961) . Similar post-perfusion loss of fibrinogen after neutralization of heparin by polybrene was noted by Gans and Krivit (1962) . Ollendorff et al. (1961) describe widespread thrombosis occurring at this stage. These findings invite caution in the neutralization of heparin, a point emphasized by Du Bourg et al. (1960) . Although it should eventually be complete, slow neutralization in stages may be preferable to the more rapid single dose technique. A recent report of a nephrotoxic effect of polybrene (Haller, Ransdell, Stowens, and Rubel, 1962) , if confirmed, may lead to the abandoning of this drug for use after extracorporeal circulation. Similar considerations of
